Nyxoah is trading at $0.90, up 5.23% on October 27, 2026, with no clear company-specific catalyst identified. - Cantor Fitzgerald maintained an Overweight rating but cut its price target to $3 from $6; this analyst action does not explain the gain. - Nyxoah will report third-quarter 2026 results on November 5, but the scheduled release is not a clear explanation for the move, which remains unexplained.